Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
International Journal of Molecular Sciences|August 12, 2023
Promise and Challenges of T Cell Immunotherapy for OsteosarcomaJeong A Park, Nai-Kong V CheungJournal of Hematology & Oncology|December 11, 2020
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcomaJeong A Park, Nai-Kong V CheungFrontiers in Immunology|June 11, 2026
Beyond the chimeric antigen receptor T cells and bispecific antibody duopoly: ex vivo armed T cells for solid tumorsJeong A Park, Nai-Kong V CheungJournal of Hematology & Oncology|September 9, 2021
Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor responseJeong A Park, Linlin Wang, Nai-Kong V CheungAnnals of Surgical Treatment and Research|April 25, 2014
Primary malignant rhabdoid tumor of greater omentum in 10-year-old girlSo-Hyun Nam, Jeong-A Park, Yeon Mee KimBiomolecules & Therapeutics|May 22, 2019
Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 CleavageSangkyu Park, Jeong-A Park, Jae-Hyung Jeon, et al.Journal of Clinical Medicine|August 29, 2024
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular ImmunotherapyNatasha V Persaud, Jeong A Park, Nai Kong V CheungOncology Letters|January 4, 2020
Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cellsSangkyu Park, Dongbum Kim, Jeong-A Park, et al.International Journal of Hematology|April 4, 2013
Favorable outcome in a child with EBV-negative aggressive NK cell leukemiaJeong A Park, Kyung Ran Jun, So Hyun Nam, et al.Redox Biology|July 18, 2017
Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cellsSangkyu Park, Jeong-A Park, Hwanmin Yoo, et al.Pageof 7